ARCHIVES

Xeloda, Taxotere, Herceptin Combination May Benefit Invasive Breast Cancer

This article is from The Cancer Letter archive.

Vol. 31 No. 1 | January 25, 2008

Download PDF Visit The Full Archive

Related Articles

NeoPharm To Begin Phase III Trial For Glioblastoma

December 26, 2003

In Brief: Clinton Signs FY95 Apparitions Into Law, to Seek $12 Billion Recision; NIH CUTS Likely

October 29, 1993

Modality Combo Decreases Prostate Cancer Recurrence

August 27, 2004

James Shannon, 89, Led NIH In 1960’s Period of Growth

May 27, 1994

16 Institutions Win NCI Awards for Phase I Trials

May 2, 2003

IDMC Recommends Halting Phase III Trial Of Onartuzumab in MET-Positive NSCLC

March 28, 2014